Neuregulin 1 (NRG1) gene fusions are rare oncogenic drivers across multiple solid tumors, and the incidence of NRG1 fusions in non-small cell lung cancer (NSCLC) was 0.26% [1]. Here, NRG1 is linked to non-small cell lung carcinoma.